Article · 16 Sep 2026
Conference abstract
Nanoparticulate drug delivery systems for modified tissue distribution and better cancer chemotherapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
New insight of diseases and pharmacokinetic information have made drug deliver totally different. It is no more just delivery of drugs, as objectives are totally different. Present approaches of design of delivery systems are more challenging and expectations are much higher. Nonselective distribution of drugs from conventional deliver systems makes dose requirement high and lead to severe side effects or toxic effects, especially in cancer chemotherapy and CNS treatment. Application of nanotechnology in drug delivery, can make modified/selective distribution, decreased dose, lesser or no side effects and better therapy. Recent studies indicated selective or modified distribution, enhanced pharmacokinetic properties and better therapeutic efficacy for nanoparticulate delivery systems of selected anticancer drugs. In vivo study of liver carcinoma therapy in animal indicated highly encouraging efficacy with enhanced overall survival when treated with nanoparticulate systems.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “R N Saha”
